MyFinsight

HomeCompareBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Total property andequipment$1,422K Cash and cashequivalents$264,197K Marketable securities,current$88,228K Prepaid expenses andother current assets$5,563K Marketable securities,noncurrent$61,103K Other assets$3,011K Operating leaseright-of-use asset$2,140K Property and equipment,net$1,206K Less accumulateddepreciation$216K Total current assets$357,988K Total noncurrentassets$67,460K Total assets$425,448K Total liabilities,redeemable convertible...$425,448K Total stockholders'equity (deficit)$398,346K Total liabilities$27,102K Accumulated deficit-$321,167K Accumulated othercomprehensive (loss) income-$95K Additional paid-in capital$719,541K Term loan$14,801K Total currentliabilities$10,809K Operating leaseliability, noncurrent$1,492K Common stock, 0.001 parvalue 700,000,000 and...$67K Accrued liabilities$7,345K Accounts payable$2,648K Operating lease liability$816K
Balance Sheet

Avalyn Pharma Inc. (AVLN)

Avalyn Pharma Inc. (AVLN)

source: myfinsight.com